These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10722507)

  • 41. Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children.
    Pelton SI; Stanley K; Yogev R; Fletcher CV; McIntosh K; Wiznia A; Nachman S;
    Clin Infect Dis; 2005 Apr; 40(8):1181-7. PubMed ID: 15791520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.
    Kuritzkes DR; Bassett RL; Johnson VA; Marschner IC; Eron JJ; Sommadossi JP; Acosta EP; Murphy RL; Fife K; Wood K; Bell D; Martinez A; Pettinelli CB
    AIDS; 2000 Jul; 14(11):1553-61. PubMed ID: 10983642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular indinavir pharmacokinetics in HIV-infected patients: comparison with plasma pharmacokinetics.
    Hennessy M; Clarke S; Spiers JP; Mulcahy F; Kelleher D; Meadon E; Maher B; Bergin C; Khoo S; Tjia J; Hoggard P; Back D; Barry M
    Antivir Ther; 2003 Jun; 8(3):191-8. PubMed ID: 12924535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A pilot study of nevirapine, indinavir, and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy.
    Harris M; Durakovic C; Rae S; Raboud J; Fransen S; Shillington A; Conway B; Montaner JS
    J Infect Dis; 1998 Jun; 177(6):1514-20. PubMed ID: 9607828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure.
    Casado JL; Dronda F; Hertogs K; Sabido R; Antela A; Martí-Belda P; Dehertogh P; Moreno S;
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):93-8. PubMed ID: 11177388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
    Eiros Bouza JM; Ortega Lafont M; Ortiz de Lejarazu R; Bachiller Luque P; de Luis Román DA
    An Med Interna; 2003 May; 20(5):239-42. PubMed ID: 12831297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pharmacokinetics of nelfinavir in HIV-1-infected children.
    van Heeswijk RP; Scherpbier HJ; de Koning LA; Heymans HS; Lange JM; Beijnen JH; Hoetelmans RM
    Ther Drug Monit; 2002 Aug; 24(4):487-91. PubMed ID: 12142631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study Team.
    Stevens RC; Rodman JH; Yong FH; Carey V; Knupp CA; Frenkel LM
    AIDS Res Hum Retroviruses; 2000 Mar; 16(5):415-21. PubMed ID: 10772527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.
    Rutschmann OT; Vernazza PL; Bucher HC; Opravil M; Ledergerber B; Telenti A; Malinverni R; Bernasconi E; Fagard C; Leduc D; Perrin L; Hirschel B
    AIDS; 2000 Sep; 14(14):2145-51. PubMed ID: 11061656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults.
    Raffi F; Reliquet V; Ferré V; Arvieux C; Hascoet C; Bellein V; Besnier JM; Breux JP; Garré M; May T; Molina JM; Perré P; Raguin G; Rozenbaum W; Zucman D
    Antivir Ther; 2000 Dec; 5(4):267-72. PubMed ID: 11142621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.
    Torre-Cisneros J; Pozo F; Serrano R; Vidal E; Rivero A; Tenorio A
    AIDS; 2000 Sep; 14(14):2215-7. PubMed ID: 11061671
    [No Abstract]   [Full Text] [Related]  

  • 54. Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudine.
    Kline MW; Calles NR; Simon C; Schwarzwald H
    Pediatr Infect Dis J; 2000 Nov; 19(11):1083-6. PubMed ID: 11099091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.
    Vigano A; Vella S; Saresella M; Vanzulli A; Bricalli D; Di Fabio S; Ferrante P; Andreotti M; Pirillo M; Dally LG; Clerici M; Principi N
    AIDS; 2000 Feb; 14(3):251-61. PubMed ID: 10716501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
    Mueller BU; Sleasman J; Nelson RP; Smith S; Deutsch PJ; Ju W; Steinberg SM; Balis FM; Jarosinski PF; Brouwers P; Mistry G; Winchell G; Zwerski S; Sei S; Wood LV; Zeichner S; Pizzo PA
    Pediatrics; 1998 Jul; 102(1 Pt 1):101-9. PubMed ID: 9651421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children.
    van Rossum AM; Bergshoeff AS; Fraaij PL; Hugen PW; Hartwig NG; Geelen SP; Wolfs TF; Weemaes CM; De Groot R; Burger DM
    Pediatr Infect Dis J; 2002 Aug; 21(8):743-7. PubMed ID: 12192162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
    JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir.
    Knudsen AD; Krebs-Demmer L; Bjørge NID; Elming MB; Gelpi M; Sigvardsen PE; Lebech AM; Fuchs A; Kühl JT; Køber L; Lundgren J; Nordestgaard BG; Kofoed KF; Nielsen SD
    J Infect Dis; 2020 Jun; 222(1):54-61. PubMed ID: 32027374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
    Haas DW; Johnson B; Nicotera J; Bailey VL; Harris VL; Bowles FB; Raffanti S; Schranz J; Finn TS; Saah AJ; Stone J
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2131-7. PubMed ID: 12821458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.